Petefészekrák: nyitott vizsgálatok itt: Dánia

22 nyitott vizsgálatnak van helyszíne itt: Dánia. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT07546500
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Kísérleti kezelés · 3. fázis · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Aalborg · Copenhagen · Roskilde
Regiszter frissítve: 2026-11-09
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Kísérleti kezelés · 2. fázis · Bayer
Aarhus University Hospital | Oncology Department - Clinical Research Unit, Aarhus N · Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense
Regiszter frissítve: 2026-11-04
NCT07213804
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Kísérleti kezelés · 3. fázis · Eli Lilly and Company
Rigshospitalet, Copenhagen · Vejle Sygehus, Vejle
Regiszter frissítve: 2026-11-04
NCT06072781
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Kísérleti kezelés · 3. fázis · Verastem, Inc.
Aalborg University Hospital, Aalborg
Regiszter frissítve: 2026-11-02
NCT06819007
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Kísérleti kezelés · 3. fázis · Daiichi Sankyo
Region Midtjylland, Aarhus N · Rigshospitalet, Copenhagen Oe · Region Sjaelland, Roskilde
Regiszter frissítve: 2026-10-28
NCT06824467
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Region Hovedstaden, Herlev · Lillebaelt Hospital, Vejle
Regiszter frissítve: 2026-10-13
NCT07059845
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Kísérleti kezelés · 2. fázis · AbbVie
Aalborg University Hospital, Aalborg · Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Regiszter frissítve: 2026-10-13
NCT07278336
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Kísérleti kezelés · 1. fázis · AbbVie
Rigshospitalet, Copenhagen Oe
Regiszter frissítve: 2026-10-13
NCT07318558
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Kísérleti kezelés · 3. fázis · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Regiszter frissítve: 2026-10-13
NCT06276491
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Kísérleti kezelés · 1. fázis · Xencor, Inc.
Herlev & Gentofte Hospital, Herlev
Regiszter frissítve: 2026-10-09
NCT06997029
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Kísérleti kezelés · 1. fázis · Bristol-Myers Squibb
Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C
Regiszter frissítve: 2026-10-06
NCT07225270
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Kísérleti kezelés · 3. fázis · Genmab
Aalborg University Hospital, Aalborg · Rigshospitalet, Copenhagen Oe · Region Sjaelland, Roskilde
Regiszter frissítve: 2026-10-06
NCT04752826
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Kísérleti kezelés · 1/2. fázis · BioInvent International AB
Rigshospitalet, Copenhagen · Herlev Hospital, Herlev
Regiszter frissítve: 2026-09-18
NCT07733505
Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?
Kísérleti kezelés · 1. fázis · Odense University Hospital
Odense University Hospital, Odense C
Regiszter frissítve: 2026-07-29
NCT07218809
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Kísérleti kezelés · 3. fázis · AstraZeneca
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Odense University Hospital, Odense C · Sygehus Lillebaelt - Vejle Sygehus, Vejle
Regiszter frissítve: 2026-07-21
NCT04641247
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Kísérleti kezelés · 2. fázis · GlaxoSmithKline
Odense C
Regiszter frissítve: 2026-06-24
NCT05574673
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
Kutatás · Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Rigshospitalet, København Ø
Regiszter frissítve: 2026-02-27
NCT06234423
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Kísérleti kezelés · 1. fázis · OnCusp Therapeutics, Inc.
Rigshospitalet, Copenhagen Oe
Regiszter frissítve: 2026-01-14
2023-503398-39-00
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
Kísérleti kezelés · 2. fázis · Aarhus University
Aarhus Universitet, Aarhus N
Regiszter frissítve: 2025-05-30
NCT05763511
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Kutatás · University of Aarhus
Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus
Regiszter frissítve: 2024-05-09
NCT05842629
Improved Diagnosis of Ovarian Cancer
Kutatás · University of Aarhus
Department of Gynaecology and Obstetrics, Aarhus University Hospital, Aarhus
Regiszter frissítve: 2024-05-09
NCT05810701
FRAGINOC Study: Screening and Geriatric Assessment and Intervention in Older Patients With Epithelial Ovarian Cancer
Kísérleti kezelés · Odense University Hospital
Copenhagen University Hospital, Rigshospitalet, Copenhagen · Herlev and Gentofte Hospital, Herlev · Odense University Hospital, Odense · Zealand University Hospital, Roskilde · Vejle Hospital, Vejle
Regiszter frissítve: 2023-04-12

Minden vizsgálat (Petefészekrák) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek